| Members |
targetComponentId |
| stavmonokromasi |
Complete achromatopsia |
| romidepsin 10 mg, injektionsvätska, lösning |
Romidepsin 10 mg powder for solution for injection vial |
| ropinirol 3 mg, depåtablett |
Ropinirole only product |
| ropivakainhydroklorid 2 mg/ml, infusionsvätska, lösning, påse 100 ml |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ropivakainhydroklorid 2 mg/ml, infusionsvätska, lösning, påse 200 ml |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ropivakainhydroklorid 5 mg/ml, injektionsvätska, lösning, ampull |
Product containing only ropivacaine in parenteral dose form (medicinal product form) |
| Rosacea |
Rosacea (disorder) |
| bengalrosa 1 %, ögondroppar |
Rose bengal only product |
| bengalrosa 1 %, ögondroppar för engångsbruk |
Rose bengal only product |
| bengalrosa 1,3 mg, ögonremsa |
Rose bengal only product |
| Roseola virus |
Human herpesvirus 6 |
| Rosiglitazone + rosiglitazone maleate 8mg/ns tablet |
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
| ross riverfeber |
Disease caused by Ross River virus (disorder) |
| rotavirusinfektion hos barn |
Viral gastroenteritis due to Rotavirus |
| rundcelligt liposarkom |
Myxoid liposarcoma (disorder) |
| rundcelligt liposarkom |
Myxoid liposarcoma |
| Rubeola virus antibody |
Measles virus antibody |
| Ruminococcus hansenii |
Blautia hansenii (organism) |
| Ruminococcus pasteurii |
Trichococcus pasteurii (organism) |
| Ruminococcus productus |
Blautia producta |
| Rupture of other tendons of foot and ankle, NEC |
Rupture of tendon of foot and ankle |
| ruptur av handledsflexorer |
Rupture of flexor tendon of wrist (disorder) |
| Rusch 10mL balloon 12Ch DT71002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 10mL balloon 18Ch DT71002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 16Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urethral catheter |
| Rusch 30mL balloon 18Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 18Ch DT83002 2-way PTFE coated female length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 20Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT83002 2-way PTFE coated female length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 24Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 26Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rz phenotype |
CDE haplotype (finding) |
| test för SH-antigen vid hepatit B |
Hepatitis B surface antigen measurement |
| SNOMED RT Concept |
SNOMED CT Concept |
| Saccharothrix coeruleoviolacea |
Goodfellowiella coeruleoviolacea (organism) |
| Saccharothrix flava |
Lechevalieria flava (organism) |
| sakrala gropar |
Sacral dimple |
| Saddle-shaped |
Saddle shape |
| trygg miljö |
Safe environment |
| saffran, livsmedel |
Saffron (substance) |
| salbutamolsulfat 100 mg/20 ml, lösning för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| salbutamol 2,5 mg/2,5 ml, för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| salbutamol 200 mikrogram, inhalationskapsel |
Salbutamol 200 microgram/actuation powder for inhalation |
| salbutamol 400 mikrogram, inhalationskapsel |
Salbutamol 400 microgram/actuation powder for inhalation |
| salbutamol 5 mg/2,5 ml, för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| salbutamol 5 mg/50 ml, injektion |
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| salbutamol 50 mg/5 ml, intravenös infusion |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| salbutamol 2,5 mg + ipratropiumbromid 500 mikrogram, för nebulisator |
Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
| Salcatonin 200iu nasal spray |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| laxkalcitonin 200 IE, nässprej |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| Salicoazosulfapyridine |
Product containing sulfasalazine (medicinal product) |
| Salicylamide |
Salicylamide |
| salicylatextrakt |
Product containing salicylate (product) |
| Salicylic acid 17% liquid |
Salicylic acid 170 mg/mL cutaneous solution |
| salicylsyra 17 %, vätska |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 17% liquid+pack |
Salicylic acid 170 mg/mL cutaneous solution |
| salicylsyraplåster 20 %, 7,5 cm x 4,5 cm |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 20% 7.5cmx4.5cm plaster |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyraplåster 40 %, 7,5 cm x 4,5 cm |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 40% 7.5cmx4.5cm plaster |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyra 1 % + antrakinonglykosider 0,5 %, för pensling i munnen |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
| salicylsyra 3 % + borsyra 5 %, puder |
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyra 3 % + borsyra i renat talk 5 %, pulver |
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyra 16,7 % + mjölksyra 16,7 %, preparat för pensling |
Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution |
| Salinococcus hispanicus |
Salinicoccus hispanicus |
| Salinococcus roseus |
Salinicoccus roseus (organism) |
| Salinococcusart |
Genus Salinicoccus |
| Salivary dysfunction caries secondary to salivary gland disease |
Salivary dysfunction dental caries |
| Salivary stone |
Sialolithiasis |
| Salmeterol xinafoate 21mcg aerosol |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salmeterol xinafoate 21mcg/spr aerosol |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| salmeterolxinafoat 21 mikrogram/sprejdos, aerosol |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| salmeterolxinafoat 38,06 mikrogram, inhalationsmedel |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| salmeterolxinafoat 50 mikrogram, pulver |
Salmeterol only product in pulmonary dose form |
| salmeterol 25 mikrogram + flutikasonpropionat 125 mikrogram, inhalator |
Fluticasone and salmeterol only product in pulmonary dose form |
| salmeterol 25 mikrogram + flutikasonpropionat 250 mikrogram, inhalator |
Fluticasone and salmeterol only product in pulmonary dose form |
| salmeterol 25 mikrogram + flutikasonpropionat 50 mikrogram, inhalator |
Fluticasone and salmeterol only product in pulmonary dose form |
| lax, livsmedel |
Salmon (substance) |
| Salmonella 1,4,12,27:b:[e,n,x} |
Salmonella II 1,4,12,27:b:[e,n,x] (organism) |
| Salmonella 16:b:e,n,x |
Salmonella Hvittingfoss (organism) |
| Salmonella 17:m,t:-- |
Salmonella Bama (organism) |
| Salmonella 3,10:b:e,n,x |
Salmonella Benfica (organism) |
| Salmonella 3,10:d:e,n,x |
Salmonella Souza (organism) |
| Salmonella 30:k:e,n,x,z15 |
Salmonella Odozi (organism) |
| Salmonella 39;m,t;e,n,x |
Salmonella II 39:[g],m,t:[e,n,x] |
| Salmonella 42:z36:-- |
Salmonella Weslaco (organism) |
| Salmonella 43:z:1,5 |
Salmonella Ogbete (organism) |
| Salmonella 44:g,z51:-- |
Salmonella Carswell (organism) |
| Salmonella 47;d;e,n,x,z15 |
Salmonella II 47:a:e,n,x,z15 |
| Salmonella 48;a;- |
Salmonella V 48:b:- |
| Salmonella 50:m,t:z6:z42 |
Salmonella II 50:m,t:z6:z42 (organism) |
| Salmonella 50:z42:1,7 |
Salmonella II 50:z42:1,7 (organism) |
| Salmonella 53:z4,z24:- |
Salmonella II Humber (organism) |
| Salmonella 6,8:a:e,n,x |
Salmonella Narashino (organism) |
| Salmonella 6,8:z:1,5 |
Salmonella Mowanjum (organism) |
| Salmonella 9,46:z10:z6 |
Salmonella Louisiana (organism) |
| Salmonella Bassa |
Salmonella Bassa (organism) |
| Salmonella Choleraesuis ss choleraesuis |
Salmonella enterica subsp. enterica (organism) |
| Salmonella Dessau |
Salmonella Dessau (organism) |
| Salmonella Goeteborg |
Salmonella Goeteborg (organism) |
FHIR